Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00770458 · ClinicalTrials.gov registry record
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
A clinical trial, sponsored by Sequenom.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00770458 is a clinical trial that has completed, run by Sequenom. The registered enrollment target is 1,000 participants.
The verdict
NCT00770458 has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00770458
The ClinicalTrials.gov registry entry for NCT00770458 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00770458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00770458 about?
NCT00770458 is a clinical study titled "Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker". Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.
What is the current status of trial NCT00770458?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2008-06. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00770458?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.